Toxic Epidermal Necrolysis Caused by Apalutamide: A Case Report of Treatment Using Etanercept with Conventional Steroid Therapy
DOI:
https://doi.org/10.2340/actadv.v102.2243Keywords:
toxic epidermal necrolysis, apalutamide, etanercept, steroid, tumour necrosis factor αAbstract
Abstract is missing (Short communication)
Downloads
References
Endo Y, Oka A, Uehara A, Toki S, Motegi SI, Ishikawa O, et al. Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug. J Dermatol 2020; 47: e359-e360.
https://doi.org/10.1111/1346-8138.15510 DOI: https://doi.org/10.1111/1346-8138.15510
Sagawa N, Watanabe Y, Mizuno Y, Takahashi S, Watanabe T, Ikeda N, et al. A case of toxic epidermal necrolysis associated with apalutamide administration. J Cutan Immunol Allergy 2020; 3: 134-135.
https://doi.org/10.1002/cia2.12138 DOI: https://doi.org/10.1002/cia2.12138
Miyagawa A, Adachi T, Kobayashi Y, Takamiyagi S, Arakawa H, Futatsugi K, et al. Plasmapheresis as a promising treatment option in apalutamide-associated toxic epidermal necrolysis. J Dermatol 2022; 49: e102-e103
https://doi.org/10.1111/1346-8138.16248 DOI: https://doi.org/10.1111/1346-8138.16248
Umemura H, Koroki Y, Iwaki Y, Imanaka K, Kamabara T, Lopez-Gitlitz A, et al. Skin rash following administration of apalutamide in Japanese patients with advanced prostate cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study. BMC Urology 2020; 20: 139.
https://doi.org/10.1186/s12894-020-00689-0 DOI: https://doi.org/10.1186/s12894-020-00689-0
Paradisi A, Abeni D, Bergamo F, Ricci F, Didona D, Didona B. Etanercept therapy for toxic epidermal necrolysis. J Am Acad Dermatol 2014; 71: 278-283.
https://doi.org/10.1016/j.jaad.2014.04.044 DOI: https://doi.org/10.1016/j.jaad.2014.04.044
Chang J, Girgis L. Clinical use of anti-TNF-α biological agents A: a guide for GPs. Aust Fam Physician 2007; 36: 1035-1038.
Published
How to Cite
License
Copyright (c) 2022 Kana Osawa, Yukiko Kiniwa, Yuzuki Shimosato, Hirotaka Midorikawa, Takushi Shirai, Tasuku Sano, Kenta Nakamura, Ryuhei Okuyama
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
